DK0771322T3 - Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf - Google Patents

Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf

Info

Publication number
DK0771322T3
DK0771322T3 DK95901912T DK95901912T DK0771322T3 DK 0771322 T3 DK0771322 T3 DK 0771322T3 DK 95901912 T DK95901912 T DK 95901912T DK 95901912 T DK95901912 T DK 95901912T DK 0771322 T3 DK0771322 T3 DK 0771322T3
Authority
DK
Denmark
Prior art keywords
extracellular products
vaccines
majorly abundant
methods
stimulate
Prior art date
Application number
DK95901912T
Other languages
English (en)
Inventor
Marcus A Horwitz
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/156,358 external-priority patent/US6752993B1/en
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0771322T3 publication Critical patent/DK0771322T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Telephone Function (AREA)
  • Stringed Musical Instruments (AREA)
  • Multi-Process Working Machines And Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95901912T 1993-11-23 1994-11-18 Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf DK0771322T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/156,358 US6752993B1 (en) 1993-11-23 1993-11-23 Abundant extracellular product vaccines and methods for their production and use
US28966794A 1994-08-12 1994-08-12
PCT/US1994/013145 WO1995014713A2 (en) 1993-11-23 1994-11-18 Abundant extracellular products and methods for their production and use

Publications (1)

Publication Number Publication Date
DK0771322T3 true DK0771322T3 (da) 2008-11-24

Family

ID=26853097

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95901912T DK0771322T3 (da) 1993-11-23 1994-11-18 Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf

Country Status (12)

Country Link
US (1) US6761894B1 (da)
EP (1) EP0771322B9 (da)
JP (2) JPH09505588A (da)
CN (1) CN1103781C (da)
AT (1) ATE407945T1 (da)
AU (1) AU1097795A (da)
BR (1) BR9408135A (da)
CA (1) CA2177249C (da)
DE (1) DE69435138D1 (da)
DK (1) DK0771322T3 (da)
ES (1) ES2313719T3 (da)
WO (1) WO1995014713A2 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
AU1097795A (en) 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use
US7300660B2 (en) 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
JPH10502366A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクター・ピロリ抗原タンパク質調製品およびイムノアッセイ
WO1996005223A1 (en) * 1994-08-12 1996-02-22 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
JPH11506320A (ja) * 1995-05-23 1999-06-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 豊富な細胞外産物、ならびにそれらを産生および使用するための方法
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
AU1463097A (en) * 1996-01-04 1997-08-01 Rican Limited Helicobacter pylori bacterioferritin
US6010855A (en) 1996-07-26 2000-01-04 Institut Pasteur Desaturase antigen of mycobacterium tuberculosis
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
JP2001512435A (ja) * 1997-01-21 2001-08-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 豊富な細胞外産物ならびにそれらの産生および使用方法
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
US6544522B1 (en) 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
MX2007005256A (es) 2004-11-16 2008-03-11 Crucell Holland Bv Vacunas multivalentes que comprenden vectores virales recombinantes.
CN102850445B (zh) * 2012-09-24 2014-01-08 张银辉 一组结核分枝杆菌菌体特异性抗原及其纯化方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888837A (en) 1973-06-28 1975-06-10 Mitsui Pharmaceuticals Tuberculin active proteins and peptides from the cells of tubercle bacilli
AU5856073A (en) 1973-06-28 1975-01-30 Toru Tsumits Tuberculin active proteins and peptides
US4123427A (en) 1976-07-27 1978-10-31 Daniel Thomas M Method for the purification of mycobacterial protein antigens and resulting product
US4460503A (en) 1983-03-15 1984-07-17 Institut Pasteur Tuberculine active peptides and a process for preparing same by chemical synthesis
GB8404280D0 (en) 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4777130A (en) 1984-12-05 1988-10-11 Andra Biologicals Isolation of mycobacterial a 60 antigen for diagnostic purposes
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4906742A (en) 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
EP0323480A1 (en) 1986-09-08 1989-07-12 Applied Biotechnology, Inc. Genetically engineered vaccines for mycobacteria
US5268170A (en) 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
AU1548388A (en) 1987-02-02 1988-08-24 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis genes and encoding protein antigens
US4976958A (en) 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
EP0681026A1 (en) 1987-03-02 1995-11-08 Whitehead Institute For Biomedical Research Recombinant mycobacterial vaccine
US5504005A (en) 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
US5225324A (en) 1987-04-24 1993-07-06 Bioscience International, Inc. Diagnostics for mycobacteria in public health, medical, and veterinary practice
WO1989005825A1 (en) 1987-12-22 1989-06-29 Immunex Corporation EXPRESSION OF RECOMBINANT 18/16.6 AND 15.2 kD PROTEIN ANTIGENS OF MYCOBACTERIUM LEPRAE
NL8703107A (nl) 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.
WO1989012455A1 (en) 1988-06-15 1989-12-28 Whitehead Institute For Biomedical Research Stress proteins and uses therefor
US5108745B1 (en) 1988-08-16 1998-06-30 Univ California Tuberculosis and legionellosis vaccines and methods for their production
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
AU5848090A (en) 1989-06-19 1991-01-08 Whitehead Institute For Biomedical Research Vector-mediated genomic insertion and expression of dna in bcg
DD295869A5 (de) * 1989-09-19 1991-11-14 �K�K@������������@�K�Kk�� Rekombinante polypeptide und peptide, diese codierende nucleinsaeuren und verwendung dieser polypeptide und peptide in der diagnose von tuberkulose
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
GB2239246A (en) 1989-12-22 1991-06-26 Astra Ab Protein antigen from Mycobacterium tuberculosis
SE9001105D0 (sv) 1990-03-27 1990-03-27 Astra Ab New methods foer diagnosis of tuberculosis
CA2045842A1 (en) 1990-07-16 1992-01-17 William R. Jacobs Dna capable of site-specific integration into mycobacteria
GB9015888D0 (en) 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5254459A (en) 1990-08-23 1993-10-19 Patarroyo Manuel E Nucleotide and amino acid sequences of protein MTP40 of M. tuberculosis and synthetic peptides derived therefrom
US5169940A (en) 1990-08-23 1992-12-08 Patarroyo Manuel E Nucleotide sequences of protein MTP40 of M. tuberculosis
US5171839A (en) 1990-08-23 1992-12-15 Patarroyo Manuel E Nucleotide and amino acid sequences of protein mtp40 of m. tuberculosis and synthetic peptides derived therefrom
EP0547166A1 (en) 1990-09-06 1993-06-23 Immulogic Pharmaceutical Corporation Pathogen-specific ctl therapy
EP0499003A1 (en) * 1991-02-14 1992-08-19 N.V. Innogenetics S.A. Polypeptides and peptides, particularly recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
CA2106962C (en) 1991-03-25 2003-10-21 Carlo Cocito Polypeptides from mycobacterium paratuberculosis
GB9111291D0 (en) 1991-05-24 1991-07-17 Medical Res Council Diagnostic peptides
EP0587775A4 (en) 1991-06-06 1994-11-02 Medimmune Inc INDUCTION OF THE CTL RESPONSE BY FOREIGN ANTIGENS EXPRESSED IN MYCOBACTERIES.
FR2677365B1 (fr) 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
JPH06511145A (ja) 1991-06-13 1994-12-15 アルバート　アインシュタイン　カレッジ　オブ　メディシン、ア　ディビジョン　オブ　イェシーバ　ユニバーシティ ミコバクテリア内での挿入突然変異
AU681572B2 (en) 1991-10-21 1997-09-04 Med Immune, Inc. Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
FR2682967B1 (fr) 1991-10-25 1994-01-14 Pasteur Institut Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques.
GB9200949D0 (en) 1992-01-17 1992-03-11 Medical Res Council Diagnostic peptides
WO1993014789A1 (en) 1992-01-22 1993-08-05 New England Medical Center Hospitals, Inc. Pathogen-specific ctl therapy
FR2687410A1 (fr) 1992-02-14 1993-08-20 Pasteur Institut Beta-lactamase recombinante, utilisable en tant que molecule porteuse pour la preparation de compositions immunogenes.
FR2688785B1 (fr) 1992-03-19 1995-07-07 Pasteur Institut Sequence peptidique apte a induire une reaction d'hypersensibilite de type retarde en presence de bacteries vivantes du complexe mycobacterium tuberculosis, et ses applications.
WO1994002508A2 (en) 1992-07-22 1994-02-03 Proteus Molecular Design Limited Polypeptide antigens of mycobacterium bovis
DK79893D0 (da) 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
AU1097795A (en) 1993-11-23 1995-06-13 Regents Of The University Of California, The Abundant extracellular products and methods for their production and use

Also Published As

Publication number Publication date
AU1097795A (en) 1995-06-13
DE69435138D1 (de) 2008-10-23
WO1995014713A2 (en) 1995-06-01
CN1142231A (zh) 1997-02-05
JP2005104983A (ja) 2005-04-21
US6761894B1 (en) 2004-07-13
CN1103781C (zh) 2003-03-26
WO1995014713A3 (en) 1995-12-28
EP0771322B9 (en) 2009-08-12
EP0771322A1 (en) 1997-05-07
EP0771322B1 (en) 2008-09-10
CA2177249C (en) 2010-10-19
JPH09505588A (ja) 1997-06-03
ES2313719T3 (es) 2009-03-01
BR9408135A (pt) 1997-08-05
ATE407945T1 (de) 2008-09-15
JP4537178B2 (ja) 2010-09-01
CA2177249A1 (en) 1995-06-01

Similar Documents

Publication Publication Date Title
DK0771322T3 (da) Rigeligt forekommende, ekstracellulære produkter og fremgangsmåder til fremstilling samt anvendelse deraf
CA2050749A1 (en) Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations
ATE26127T1 (de) Rekombinante dna, damit transformierte wirtsorganismen und durch die wirtsorganismen hergestellte polypeptide; verfahren zu ihrer herstellung; nachweisverfahren unter benutzung der polypeptide; die polypeptide enthaltende zusammensetzungen und mittel; dna-sequenzen.
NO331103B1 (no) Polypeptid for induksjon av immunrespons mot Streptococcus Pneumoniae, polynukleotid og ekspresjonsvektor inneholdende dette samt vertscelle og fremgangsmate for produksjon av polypeptidet og vaksinesammensetning omfattende dette
CY1106350T1 (el) Εμβολιο φυματιωσης
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
BR9608894A (pt) Produtos extracelulares abundantes e processos para suas producões e usos
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
EP1005365A4 (en) ABUNDANT EXTRACELLULAR PRODUCTS AND METHODS OF PRODUCING AND USING THE SAME
DK0914437T3 (da) Identificering og kloning af et mykobakterieantigen svarende til et heparinbindende hæmagglutinin
WO2000012535A3 (en) Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
DE602004027362D1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
DK0892054T3 (da) Clostridium perfringens-vaccine
WO2020065349A8 (en) Vaccines and methods
MX9701103A (es) Productos extracelulares abundantes y metodos para su produccion y uso.
DE60042268D1 (de) Deletierte sequenzen in m. bovis bcg / m. bovis oder m. tuberculosis, verfahren zur erkennung von mycobakterien mit diesen sequenzen und vakzine
WO2000039301A3 (en) Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
WO1998040497A3 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
KR900701831A (ko) 열대열 말라리아 원충의 분열소체 표면 항원의 대립형질 변이주
WO2005060328A3 (en) ENCODING NUCLEOTIDES OF GENES FROM THE CHROMOSOME OF THE BACTERIUM Mycoplasma hyopneumoniae, EXPRESSION AND ACTIVITY OF THE POLYNUCLEOTIDES AND THEIR APPLICATIONS
EP4275700A3 (en) Vaccine immunogens
ATE305941T1 (de) Impfstoff
DE60031106D1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.